Read More

Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance

Elevance Health reports Q1 revenues at $42.3 billion, surpassing expectations. CEO Gail Boudreaux highlights strategic growth initiatives, with profit up 12.2% Y/Y and adjusted EPS at $10.64. Medicaid membership decline offset by commercial and ACA enrollment.

ELV

Read More

Apogee Enterprises Forecasts Topline Decline In FY25 Amid Strategic Actions: Details

Apogee Enterprises shines in Q4 FY24, surpassing expectations with robust sales growth of 5.2% year-on-year, reaching $361.84 million. The company's strategic initiatives, including enhanced pricing and optimized product mix, drove a notable 13.3% increase in gross profit to $88.5 million, marking a gross margin improvement of 170 bps to 24.4%.

APOG

Read More

Mytheresa Announces Preliminary Q3 GMV In The Range Of €245 Million To €255 Million; Net Sales In The Range Of €230 Million To €235 Million; Sees FY24 GMV And Net Sales Growth In The Range Of 8%-13%

MYT Netherlands Parent B.V. (NYSE:MYTE) ("Mytheresa" or the "Company"), today announced preliminary unaudited financial results for the third quarter ended March 31, 2024, and confirmed the guidance for the full fiscal

MYTE